A Q4 2025 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q4 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.9B+9.4% YoY

Gross Profit

$964M51.8% margin

Operating Income

$443M23.8% margin

Net Income

$434M23.3% margin

EPS (Diluted)

$1.53

QoQ Revenue Growth

+7.1%

Cash Flow

Operating Cash Flow

$545M

Free Cash Flow

$452M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$12.7B

Total Liabilities

$6.0B

Stockholders' Equity

$6.7B

Cash & Equivalents

$1.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.9B	$1.7B	+9.4%
Gross Profit	$964M	$916M	+5.2%
Operating Income	$443M	$408M	+8.6%
Net Income	$434M	$351M	+23.6%

Revenue Segments

Agilent CrossLab

$755M41%

Life Sciences and Applied Markets

$755M41%

Applied Markets

$351M19%

Geographic Segments

Americas

$776M42%

Asia Pacific

$559M30%

Europe

$526M28%